Visiting Lecturer and Former Government Adviser To Nice Uk · United Kingdom
Can we afford a Cure? Paying for innovation with new cancer medicines With new innovative medicines comes ever increasing drug prices; we explore the challenges facing governments and healthcare institutions to providing timely access to life saving medicines The increasing creativity in negotiations between drug companies and governments are seeing a growth in innivative contractign and value based agreements; where, if the drug doesnt work - then we dont pay ! This presentation will showcase global trends and explore some amazing case studies whereby the unafordable hasbecome affordable, allowing for patients to access multi-million dollar drugs.